Treatt plc (LON:TET - Get Free Report)'s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 340.70 ($4.63) and traded as low as GBX 245.41 ($3.33). Treatt shares last traded at GBX 246.50 ($3.35), with a volume of 117,528 shares traded.
Treatt Trading Up 0.6%
The company has a quick ratio of 0.87, a current ratio of 4.06 and a debt-to-equity ratio of 1.78. The firm's 50 day simple moving average is GBX 264.36 and its two-hundred day simple moving average is GBX 340.70. The stock has a market cap of £149.94 million, a P/E ratio of 13.40 and a beta of 1.02.
Treatt (LON:TET - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported GBX 4.49 ($0.06) earnings per share (EPS) for the quarter. Treatt had a return on equity of 8.09% and a net margin of 7.88%. As a group, equities research analysts predict that Treatt plc will post 27.0420792 earnings per share for the current fiscal year.
About Treatt
(
Get Free Report)
We are a trusted ingredients manufacturer and solutions provider to the global flavour, fragrance and consumer goods markets from our bases in the UK, the US and China. We take pride in developing the ingredient solutions of the future and are supported by a global operational infrastructure that delivers results.
Further Reading
Before you consider Treatt, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Treatt wasn't on the list.
While Treatt currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
